Conversion of subendothelial macrophages into cholesterol-laden foam cells is believed to constitute the foundation of the atherosclerotic lesion

The conversion of subendothelial macrophages into cholesterol-laden foam cells is believed to constitute the foundation of the atherosclerotic lesion. Native LDL has traditionally not been considered capable of generating foam cells because cells downregulate their LDL receptor number with increasing cellular cholesterol content, precluding lipid loading via this pathway []. Modification of LDL is therefore required to drive lipid uptake by alternative receptor pathways. Over the past thirty years, multiple means have been identified to alter LDL structure that facilitate its conversion of macrophages into lipid-laden foam cells. The widely accepted paradigm for the in vivo modification responsible for the alternative receptor binding behavior of LDL has been the oxidative modification hypothesis, most cogently proposed by Steinberg and colleagues in 1989 []. This theory posits that heightened oxidative stress in the vascular wall and its associated production of reactive oxygen and nitrogen species give rise to oxidized forms of LDL that are recognized by a family of scavenger receptors that we now recognize to be members of the innate immunity PRR class []. This family includes eight subclasses of structurally unrelated receptors that share the defining feature of being able to bind and internalize modified forms of LDL (; reviewed in []). As suggested by their name, these receptors also recognize and “scavenge” other modified-self and non-self ligands, including bacteria, apoptotic cells, anionic phospholipids and amyloid proteins. The phagocytic function of these evolutionarily ancient receptors is believed to have its roots in tissue remodeling and host defense, however new evidence suggests that scavenger receptors can also direct cellular signal transduction either alone, or by pairing with dedicated signaling receptors such as the Toll-like receptors [], which are discussed in greater detail below.
Conversion of subendothelial macrophages into cholesterol-laden foam cells is believed to constitute the foundation of the atherosclerotic lesion

Publication

Targeting Innate Immunity for CV Benefit. () Kathryn J. Moore, et al. Drug Discov Today Ther Strateg. ;5(1):15-23. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates SR-PSOX SR-PSOX ncbigene_synonym CXCL16 58191
Homo sapiens Primates SR-A SR-A ncbigene_synonym MSR1 4481
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR1 7096
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR2 7097
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR3 7098
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR4 7099
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR5 7100
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR6 10333
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR7 51284
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR8 51311
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR9 54106
Homo sapiens Primates CD36L,TLR? TLR famplex_relations TLR10 81793
Homo sapiens Primates SREC-I SREC-I ncbigene_synonym SCARF1 8578
Homo sapiens Primates SREC-II SREC-II ncbigene_synonym SCARF2 91179
Homo sapiens Primates Lyn LYN ncbigene_symbol LYN 4067
Homo sapiens Primates Fyn FYN ncbigene_symbol FYN 2534
Homo sapiens Primates MARCO MARCO ncbigene_symbol MARCO 8685
Homo sapiens Primates LOX-1 LOX1 ncbigene_synonym OLR1 4973
Homo sapiens Primates CD68 CD68 ncbigene_symbol CD68 968
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL10 3627
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL11 6373
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL12 6387
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL13 10563
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL14 9547
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL9 4283
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations PF4 5196
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL1 2919
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL2 2920
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL3 2921
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL5 6374
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL6 6372
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations CXCL8 3576
Homo sapiens Primates →Chemokines CHEMOKINE famplex_relations PPBP 5473
Homo sapiens Primates AP1 AP1 ncbigene_synonym FOS 2353
Homo sapiens Primates AP1 AP1 ncbigene_synonym FOSB 2354
Homo sapiens Primates AP1 AP1 ncbigene_synonym JUN 3725
Homo sapiens Primates AP1 AP1 ncbigene_synonym JUNB 3726
Homo sapiens Primates AP1 AP1 ncbigene_synonym JUND 3727
Homo sapiens Primates AP1 AP1 famplex_relations FOSL1 8061
Homo sapiens Primates AP1 AP1 famplex_relations FOSL2 2355
Homo sapiens Primates NFKB NFKB ncbigene_synonym NFKB1 4790
Homo sapiens Primates NFKB NFKB famplex_relations RELA 5970
Homo sapiens Primates NFKB NFKB famplex_relations RELB 5971
Homo sapiens Primates NFKB NFKB famplex_relations REL 5966
Homo sapiens Primates NFKB NFKB famplex_relations NFKB2 4791

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID
Cancer NA